Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1/hepatitis B coinfection.

Yves Benhamou1

  • 1Service d'Hépato-Gastroentérologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. ybenhamou@teaser.fr

Expert Review of Anti-Infective Therapy
|May 28, 2005
PubMed
Summary

This review covers the epidemiology, natural history, and current treatment of HIV/hepatitis B coinfection. It provides an overview of managing this dual viral infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

The lancet. Gastroenterology & hepatology·2016
Same author

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

Gastroenterology·2016
Same author

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).

Hepatology (Baltimore, Md.)·2016
Same author

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).

Gut·2015
Same author

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).

Hepatology (Baltimore, Md.)·2015
Same author

Cure of HCV related liver disease.

Liver international : official journal of the International Association for the Study of the Liver·2014

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis B virus (HBV) infection is common in individuals with human immunodeficiency virus (HIV).
  • Coinfection with HIV and HBV presents unique challenges in management and treatment.
  • Understanding the interplay between these viruses is crucial for effective patient care.

Purpose of the Study:

  • To review the current epidemiology of HIV/hepatitis B coinfection.
  • To describe the natural history of this coinfection.
  • To summarize the current treatment strategies for patients with HIV and HBV.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of natural history studies.
  • Synthesis of current treatment guidelines and clinical trial outcomes.

Main Results:

  • The prevalence of HBV in HIV-infected populations varies globally.
  • HIV accelerates HBV disease progression, increasing risks of cirrhosis and hepatocellular carcinoma.
  • Current treatment involves potent antiretroviral therapy and specific HBV-directed therapies.

Conclusions:

  • Effective management of HIV/hepatitis B coinfection requires integrated care.
  • Antiretroviral therapy plays a role in controlling HBV replication.
  • Ongoing research is needed to optimize treatment regimens and improve outcomes.

Related Experiment Videos